Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,524.40
(
0.23%
)
Dow Jones
48,861.81
(
-0.57%
)
Brent Oil
111.21
(
-1.04%
)
Bitcoin
76,040.44
(
0.35%
)
News Focus
News Focus
Post# of 517653
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Steady_T

Send PM Follow Ignore
Followers 170
Posts 23080
Boards Moderated 1
Alias Born 12/09/2004

Steady_T

Member Level

Re: tredenwater2 post# 173441

Saturday, 12/01/2018 1:24:58 PM

Saturday, December 01, 2018 1:24:58 PM

Post# of 517653
Please understand that the biomarker that AVXL is using is not for the AD disease, it is for the effectiveness of 2-73. Those are not the same things.

I have seen nothing that indicates that the biomarkers Anavex has identified can be used in AD disease diagnosis or progression.

If investing was easy, everyone would be rich by now.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News